The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A model to predict the feasibility of concurrent chemoradiotherapy with temozolomide in glioblastoma multiforme patients over age 65.
Florian Putz
No relevant relationships to disclose
Sergej Potapov
No relevant relationships to disclose
Godehard Lahmer
No relevant relationships to disclose
Rolf Buslei
No relevant relationships to disclose
Oliver Ganslandt
No relevant relationships to disclose
Marga Lang-Welzenbach
No relevant relationships to disclose
Rainer Fietkau
No relevant relationships to disclose
Sabine Semrau
No relevant relationships to disclose